CME

+ Watchlist + Portfolio

CME Group Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $266.94
52-Week Range: $218.31 – $329.16
Market Cap: $97.40B
P/E (TTM): 22.96
EPS (TTM): 11.80
Dividend Yield: 1.95%

Advanced Metrics

Price/Book: 3.67
PEG Ratio: 4.68
Return on Equity: 15.80%
Return on Assets: 1.48%
Gross Margin: 100.00%
Operating Margin: 65.04%
Profit Margin: 63.44%
Current Ratio: 1.02
Debt/Equity: 0.15
Total Debt: $3.87B
Free Cash Flow: $2.91B
Revenue Growth: 0.80%
Earnings Growth: 2.50%
Enterprise Value: $97.58B

CME Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$5.02B	$5.58B	$6.13B	$6.52B
Cost of Revenue	$753.10M	$828.60M	$850.30M	$907.00M
Gross Profit	$4.27B	$4.75B	$5.28B	$5.61B
Selling, General & Admin	$137.40M	$144.40M	$132.70M	$150.50M
Operating Expenses	$1.25B	$1.31B	$1.35B	$1.38B
Operating Income	$3.02B	$3.44B	$3.93B	$4.23B
EBITDA	$4.02B	$4.67B	$5.04B	$5.83B
Pretax Income	$3.49B	$4.15B	$4.54B	$5.33B
Income Tax	$799.30M	$927.40M	$1.02B	$1.26B
Net Income	$2.69B	$3.23B	$3.53B	$4.07B
Diluted EPS	7.40	8.86	9.67	11.16
Diluted Shares	359.18M	359.50M	359.94M	360.31M

CME Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$2.72B	$2.91B	$2.89B	$4.42B
Receivables	$483.20M	$535.60M	$573.10M	$639.20M
Current Assets	$139.08B	$94.89B	$103.03B	$165.36B
Total Assets	$174.18B	$129.71B	$137.45B	$198.42B
Current Liabilities	$137.69B	$93.42B	$102.31B	$160.30B
Long-Term Debt	$3.42B	$3.43B	$2.68B	$3.42B
Total Debt	$3.44B	$3.43B	$3.43B	$3.42B
Total Liabilities	$147.30B	$102.97B	$110.96B	$169.70B
Retained Earnings	$4.75B	$4.46B	$4.19B	$6.43B
Shareholders' Equity	$26.88B	$26.74B	$26.49B	$28.73B
Working Capital	$1.39B	$1.47B	$719.60M	$5.06B
Net Debt	$718.30M	$513.40M	$535.60M	—

CME Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$3.06B	$3.45B	$3.69B	$4.28B
Capital Expenditure	-$89.70M	-$76.40M	-$94.00M	-$83.50M
Free Cash Flow	$2.97B	$3.38B	$3.60B	$4.19B
Depreciation & Amortisation	$362.60M	$352.60M	$336.80M	$330.90M
Stock-Based Compensation	$84.30M	$82.90M	$89.50M	$94.80M
Investing Cash Flow	-$489.80M	$20.90M	-$82.60M	$1.50B
Financing Cash Flow	-$25.38B	-$48.34B	$5.08B	$56.51B
Dividends Paid	-$2.63B	-$3.24B	-$3.58B	-$3.93B
Share Repurchases	—	$0.00	$0.00	-$266.10M
Net Change in Cash	-$22.82B	-$44.86B	$8.68B	$62.29B

CME Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$1.69B	$1.54B	$1.65B	$1.88B	$1.71B
Cost of Revenue	$221.60M	$237.60M	$241.10M	$223.00M	$233.50M
Gross Profit	$1.47B	$1.30B	$1.41B	$1.66B	$1.47B
Selling, General & Admin	$37.40M	$36.70M	$47.90M	$28.20M	$29.10M
Operating Expenses	$341.10M	$327.40M	$388.00M	$347.40M	$365.60M
Operating Income	$1.13B	$972.60M	$1.02B	$1.31B	$1.11B
EBITDA	$1.46B	$1.30B	$1.70B	$1.64B	$1.46B
Pretax Income	$1.33B	$1.18B	$1.58B	$1.51B	$1.33B
Income Tax	$305.20M	$269.00M	$395.50M	$356.60M	$285.90M
Net Income	$1.03B	$908.00M	$1.18B	$1.15B	$1.04B
Diluted EPS	2.81	2.49	3.24	3.18	2.88
Diluted Shares	360.36M	360.42M	360.23M	363.21M	361.28M

CME Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$1.98B	$2.45B	$4.42B	$2.39B	$2.14B
Receivables	$667.60M	$642.90M	$639.20M	$935.50M	$753.10M
Current Assets	$145.45B	$152.80B	$165.36B	$169.00B	$161.63B
Total Assets	$179.91B	$187.14B	$198.42B	$201.99B	$194.68B
Current Liabilities	$142.79B	$149.59B	$160.30B	$166.00B	$158.72B
Long-Term Debt	$3.42B	$3.42B	$3.42B	$3.42B	$3.42B
Total Debt	$3.42B	$3.42B	$3.42B	$3.42B	$3.42B
Total Liabilities	$152.17B	$158.95B	$169.70B	$175.38B	$168.16B
Retained Earnings	$5.25B	$5.71B	$6.43B	$4.88B	$5.46B
Shareholders' Equity	$27.74B	$28.19B	$28.73B	$26.62B	$26.52B
Working Capital	$2.66B	$3.21B	$5.06B	$3.00B	$2.91B
Net Debt	$1.44B	$974.50M	—	$1.03B	$1.28B

CME Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$1.06B	$968.10M	$1.13B	$1.26B	$947.10M
Capital Expenditure	-$18.40M	-$18.40M	-$32.50M	-$21.80M	-$23.60M
Free Cash Flow	$1.04B	$949.70M	$1.10B	$1.24B	$923.50M
Depreciation & Amortisation	$83.40M	$82.60M	$82.40M	$83.30M	$84.20M
Stock-Based Compensation	$20.70M	$24.00M	$28.90M	$21.80M	$24.80M
Investing Cash Flow	-$18.00M	-$19.10M	$1.55B	-$23.00M	-$29.40M
Financing Cash Flow	$21.00B	$6.40B	$9.90B	$2.12B	-$8.09B
Dividends Paid	-$455.30M	-$455.30M	-$455.00M	-$2.70B	-$468.10M
Share Repurchases	-$8.20M	$0.00	-$257.90M	-$538.70M	-$698.20M
Net Change in Cash	$22.04B	$7.35B	$12.59B	$3.35B	-$7.17B

Market Snapshot

About

CME Group Inc. is the world's largest operator of financial derivatives exchanges, headquartered in Chicago, Illinois. The company operates the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX), providing platforms for trading in agricultural products, currencies, energy, interest rates, metals, futures contracts, options, stock indexes, and cryptocurrencies futures. CME Group offers the widest range of global benchmark products across all major asset classes through its electronic trading platform CME Globex, a global matching platform for all of its products. The company also operates CME Clearing, which serves as a counterparty to every cleared transaction, including both listed and over-the-counter (OTC) derivatives within its marketplace, with offices in major financial centers worldwide.